In this issue:
Mental health and agreement of patient and physician psoriasis severity ratings
DLQI at initiation or switching of biologics in plaque psoriasis
Psoriasis and all-cause mortality
All-cause and cause-specific mortality in psoriasis and psoriatic arthritis
Guidance on psoriatic disease during the COVID-19 pandemic
IL-17A/F nanobody sonelokimab for plaque psoriasis
Immune checkpoint-mediated psoriasis
Apremilast and methotrexate for palmoplantar psoriasis
Generalised pustular psoriasis flares
PsoWell™ model for management of complex psoriasis
Drug survival and safety profile of acitretin monotherapy
Please login below to download this issue (PDF)